Wird geladen...
Adenosine 2A Receptor Antagonists for the Treatment of Motor Symptoms in Parkinson's Disease
BACKGROUND: Treatment of motor fluctuations in Parkinson's disease (PD) remains an unmet challenge. Adenosine 2A (A(2A)) receptors are located along the indirect pathway and represent a potential target to enhance l‐3,4‐dihydroxyphenylalanine (l‐DOPA) antiparkinsonian action. METHODS: This arti...
Gespeichert in:
| Veröffentlicht in: | Mov Disord Clin Pract |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6178748/ https://ncbi.nlm.nih.gov/pubmed/30363540 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mdc3.12187 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|